Sobi named UK’s top haemophilia company
Tops IPC Associates’ 2016 ranking
Read More
Author: Dominic Tyer
FDA to fast-track Pfizer/Sangamo gene therapy orphan drug
SB-525 is being developed to treat haemophilia A
Read More
Aspen Pharmacare hit by EU antitrust cancer drug price probe
European regulators will investigate pricing of five oncology treatments
Read More
NHS could save £67 million a year if smoking rates cut
But would need rates to drop to 5 percent
Read More
ReNeuron wins £1.8 million for cell therapy development
Innovate UK grant will help advance its manufacturing capabilities
Read More- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
